-
Humphrey O Atiemo
[show abstract]
[hide abstract]
ABSTRACT: The concept of prophylactic anti-incontinence surgery for women undergoing prolapse repair has been a popular and controversial debate in recent years. This article provides an evidence-based review of the current literature to determine the proper evaluation of the patient with prolapse, the predictive quality of preoperative urodynamics, and the selection of the appropriate anti-incontinence procedure. Based on this review, the midurethral sling predominates as the procedure of choice; however, there is poor evidence to suggest that routine usage of a prophylactic sling is warranted in treatment of the patient with pelvic organ prolapse.
Current Urology Reports 09/2010; 11(5):304-9.
-
[show abstract]
[hide abstract]
ABSTRACT: Vesicovaginal and urethrovaginal fistulas related to obstetrical causes are exceptionally rare in the developed world. We report a case of 23-year-old woman with a urethrovaginal fistula, which developed after a cesarean delivery because of an inappropriately placed urethral catheter. Diagnostic evaluation and surgical approach are discussed.
Canadian Urological Association journal = Journal de l'Association des urologues du Canada 09/2009; 3(4):E21-E22. · 1.24 Impact Factor
-
[show abstract]
[hide abstract]
ABSTRACT: Men who become persistently incontinent after undergoing prostatectomy have a variety of options for regaining control, ranging from behavioral changes to surgery. To determine the best therapy, one should define the problem with a thorough urologic evaluation.
Cleveland Clinic Journal of Medicine 02/2007; 74(1):57-63. · 3.77 Impact Factor
-
[show abstract]
[hide abstract]
ABSTRACT: The refractory overactive bladder patient is a complex new entity for the urologic community. We present the most current review of this difficult subject matter with an emphasis on evaluation and new treatment options such as sacral neuromodulation and botulinum toxin injection. It is hoped that in this new era of medical innovation, extirpation and reconstruction of the bladder will become historic in nature and refractory therapy can be transitioned to the office and outpatient operation rooms.
Current Urology Reports 10/2006; 7(5):370-5.
-
[show abstract]
[hide abstract]
ABSTRACT: Sildenafil citrate is an effective first line agent for most causes of erectile dysfunction. Primary care providers (PCPs) write the majority of these prescriptions and most failures of sildenafil therapy are subsequently referred to urologists for alternative therapies. Often it is concluded that the drug is ineffective when in actuality the failure is do to inadequate patient education. We examined patients referred from PCPs who were nonresponders to sildenafil therapy and attempted to convert them to responders through reeducation.
In a 2-year period 253 sildenafil nonresponders were evaluated by the same urologist (GNS). Patient reeducation consisted of viewing a brief videotape, personal instruction and detailed instruction sheets for the patient and his partner. Outcome measures were obtained through patient self-reporting of the Sexual Health Inventory for Men and a global assessment question. Responders were identified as those who answered positively latter or had a statistical improvement in the score of the former.
Of the 253 patients reeducated 17 were excluded due to contraindications. Of the remaining nonresponders 41.5% achieved salvage with reeducation. Incorrect administration accounted for 81% of the failures. Average time with the physician was 12 minutes and 94% of the patients continued to respond at 26 months.
Approximately 40% of patients with sildenafil failures referred from PCPs can be converted to responders through reeducation. Incorrect drug administration was the most common reason for correctable failure. Reeducation can be done in an efficient manner. New package materials may improve sildenafil outcomes and compliance.
The Journal of Urology 01/2004; 170(6 Pt 1):2356-8. · 3.75 Impact Factor
-
The Journal of Urology 08/2003; 170(1):177. · 3.75 Impact Factor